Skip to content

The Norwegian Dietary Guidelines and Colorectal Cancer Survival Study

The Norwegian Dietary Guidelines and Colorectal Cancer Survival Study: A Food-based Multicentre Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01570010
Acronym
CRC-NORDIET
Enrollment
503
Registered
2012-04-04
Start date
2012-03-01
Completion date
2040-12-31
Last updated
2026-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Brief summary

The current study is designed to gain a better understanding of the role of a healthy diet aimed at dampening inflammation and oxidative stress on long-term disease outcomes and survival in colorectal cancer patients. Since previous research on the role of diet for colorectal cancer survivors is limited, the study may be of great importance for this cancer population.

Detailed description

Men and women aged 50-80 years diagnosed with primary invasive colorectal cancer (Stage I-III) are invited to this randomized controlled, parallel two-arm trial 2-9 months after curative surgery. The intervention group (n = 250) receives an intensive dietary intervention lasting for 12 months and a subsequent maintenance intervention for 14 years. The control group (n = 250) receives no dietary intervention other than standard clinical care. Both groups are offered equal general advice of physical activity. Patients are followed-up at 6 months and 1, 3, 5, 7, 10 and 15 years after baseline. The study center is located at the Department of Nutrition, University of Oslo, and patients are recruited from two hospitals within the South-Eastern Norway Regional Health Authority. Primary outcomes are disease-free survival and overall survival. Secondary outcomes are time to recurrence, cardiovascular disease-free survival, compliance to the dietary recommendations and the effects of the intervention on new comorbidities, intermediate biomarkers, nutrition status, physical activity, physical function and quality of life.

Interventions

OTHERNorwegian food based dietary guidelines

several means will be applied to guide participarts to cohere to the dietary guidelines including access to clinical nutritionists, free food, food discounts, cooking courses, cookbook/recipies, study website, organized physical activity, etc

Sponsors

University of Oslo
Lead SponsorOTHER
Oslo University Hospital
CollaboratorOTHER
Finnish Institute for Health and Welfare
CollaboratorOTHER_GOV
University Hospital, Akershus
CollaboratorOTHER
Norwegian Cancer Society
CollaboratorOTHER
The Research Council of Norway
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Intervention model description

Parallel randomized clinical trial

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* colorectal cancer (ICD10 C18-20) TNM Stage I-III

Exclusion criteria

* TNM stage 0 or IV

Design outcomes

Primary

MeasureTime frameDescription
Disease-free survival5, 10 and 15 yearsDisease-free survival (DFS) (events are defined as detection of local recurrence or metastasis or any second cancer or death from any cause)
Overall survival5, 10 and 15 yearsOverall survival (OS) (event is defined as death from any cause)

Secondary

MeasureTime frameDescription
Time to recurrenceup to 15 yearsEvents are defined as detection of local recurrence or metastasis
CVD -free survivalup to 15 yearsEvents of CVD (ICD-10; chapter I) or death from any cause
CRC-specific survivalup to 15 yearsdeath due to CRC
Total cancer-specific survivalup to 15 yearsdeath due to CRC or any other cancer
Inflammatory disease-specific survivalup to 15 yearsdeath due to inflammatory disease
Cardiovascular (CVD)-specific survivalup to 15 yearsdeath due to CVD
New morbidity of other diet-related chronic diseasesup to 15 yearse.g. ischemic coronary heart disease, cerebrovascular disease, thromboembolic disease, type 2 diabetes, obesity, hypertension and chronic obstructive pulmonary disease
Dietary intake and nutritional statusup to 15 yearsQuestionnaires, food records, clinical consultation
Physical activity and functionup to 15 yearsQuestionnaires, arm band, physical tests
Nutrition biomarkersup to 15 yearse.g., carotenoids, fatty acids, 25-hydroxy vitamin D etc
Body compositionup to 15 yearsDXA, CT, BIA
Anthropometric measuresup to 15 yearseg weight, waist and hip circumference
Biomarkers for inflammation and oxidative stressup to 15 yearse.g. isoprostanes, cytokines
Transcription- and epigenetic profilesup to 15 yearssequencing and arrays
Biomarkers for cardiovascular disease, metabolic syndrome, type 2-diabetes, thromboembolic disease and cancerup to 15 yearse.g. blood pressure, total/LDLcholesterol, HbA1c, CRP, IL-6, IL-10, TNFα
Health related quality of life and fatigueup to 15 yearsQuestionnaires

Countries

Norway

Contacts

PRINCIPAL_INVESTIGATORRune Blomhoff, Professor

University of Oslo

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 26, 2026